Selvita to Present at Biotech Showcase 2019 in San Francisco

Krakow, Poland – 2 January 2019 – Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, today announced that Chief Executive Officer Pawel Przewiezlikowski will present a corporate overview at the Biotech Showcase 2019 conference taking place Jan. 7-9…

More

Selvita demonstrates dynamic business growth in Q3 2018

Krakow, Poland – 20 November 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies, has recently published quarterly financial results demonstrating its continued dynamic business growth. In Q3 2018 Selvita Group recognized total commercial revenue (not…

More

...23456...1020...